Cardiovascular complications and cardiovascular death are rare in severe COVID-19 presenting with myocardial injury or failure

Abstract SARS-COV2 infection has been linked to cardiovascular complications. Published data suggest that cardiac injury may be a common disease feature and contribute to morbidity and mortality in severe COVID-19. Since early in the pandemic, little data has emerged describing what cardiovascular complications arise from myocardial injury in severe COVID-19 and whether these complications contribute to mortality. We set out to describe the incidence and nature of cardiovascular complications in patients with severe COVID-19 infection and biochemical or imaging evidence of myocardial injury. We analyzed consecutive patients admitted for severe COVID-19 and presenting with biochemical or echocardiographic evidence of myocardial injury across 16 centers within the CARDIO-COVID investigator-initiated consortium. A light-GBM machine learning model was used to identify variables associated with mortality. Our study included 1,328 patients. ICU mortality was 29.4%. Factors most associated with mortality were age, SOFA Cardiovascular score, elevated troponin, intubation, high vasoactive-inotropic score (VIS), high PEEP, and high FiO2. Individual cardiovascular (myocardial infarction, stroke, pulmonary embolism, myocarditis, VT/VF, new onset heart failure) complications were rare (all < 5%) but common in sum (17.6%), and did not present significant association with mortality. Patients with high VIS and SOFA Cardiovascular scores had a significantly higher incidence of secondary bacterial pneumonias suggesting septic shock played a role in their physiology. Investigator-adjudicated cause of death data identified respiratory failure and septic shock as primary causes of mortality. Though cardiovascular complications of severe COVID-19 are common, they do not seem to contribute significantly to mortality. Elevated cardiac enzymes and myocardial dysfunction carry prognostic value likely reflecting myocardial strain in the setting of multisystem organ dysfunction rather than direct myocardial injury by SARS-CoV2.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-16
DOI
https://doi.org/10.1038/s41598-026-75824-2
Primary Topic
COVID-19 Clinical Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Cardiovascular complications and cardiovascular death are rare in severe COVID-19 presenting with myocardial injury or failure

Michaël Mayette, Rushi V. Parikh, François Martin Carrier, Christopher F. Barnett et al.
1 links
Scientific Reports
COVID-19 Clinical Research Studies
article

Cardiovascular complications and cardiovascular death are rare in severe COVID-19 presenting with myocardial injury or failure

Michaël Mayette, Rushi V. Parikh, François Martin Carrier, Christopher F. Barnett, Fatma Güntürkün, Dekel Stavi, Sameer Khanijo, Juka S. Kim, Mitchell Zekhtser, Alberto Goffi, Vanessa Moll, Babar Fiza, Melanie D. Ashland, Donald D. Chang, Shikha Kapil, Karl Courchesne, Connor O’Brien, Thomas C. Daubert, Yasmine Ennehas, Paul K. Mohabir, Yaowei Deng, Shaun Thompson, Ryan Ruaysungnoen, Andrea Daly, Nibras Burghrara, Andrew Patterson, Clara Castellucci
article en

Abstract

Abstract SARS-COV2 infection has been linked to cardiovascular complications. Published data suggest that cardiac injury may be a common disease feature and contribute to morbidity and mortality in severe COVID-19. Since early in the pandemic, little data has emerged describing what cardiovascular complications arise from myocardial injury in severe COVID-19 and whether these complications contribute to mortality. We set out to describe the incidence and nature of cardiovascular complications in patients with severe COVID-19 infection and biochemical or imaging evidence of myocardial injury. We analyzed consecutive patients admitted for severe COVID-19 and presenting with biochemical or echocardiographic evidence of myocardial injury across 16 centers within the CARDIO-COVID investigator-initiated consortium. A light-GBM machine learning model was used to identify variables associated with mortality. Our study included 1,328 patients. ICU mortality was 29.4%. Factors most associated with mortality were age, SOFA Cardiovascular score, elevated troponin, intubation, high vasoactive-inotropic score (VIS), high PEEP, and high FiO2. Individual cardiovascular (myocardial infarction, stroke, pulmonary embolism, myocarditis, VT/VF, new onset heart failure) complications were rare (all < 5%) but common in sum (17.6%), and did not present significant association with mortality. Patients with high VIS and SOFA Cardiovascular scores had a significantly higher incidence of secondary bacterial pneumonias suggesting septic shock played a role in their physiology. Investigator-adjudicated cause of death data identified respiratory failure and septic shock as primary causes of mortality. Though cardiovascular complications of severe COVID-19 are common, they do not seem to contribute significantly to mortality. Elevated cardiac enzymes and myocardial dysfunction carry prognostic value likely reflecting myocardial strain in the setting of multisystem organ dysfunction rather than direct myocardial injury by SARS-CoV2.

Scientific Reports
University of North Carolina at Chapel Hill (US), MedStar Washington Hospital Center (US), University of Minnesota (US), Université de Sherbrooke (CA), Henry Ford Health System (US), University of California, Los Angeles (US), University of California, San Francisco (US), University of Toronto (CA), University of Zurich (CH), Tel Aviv Sourasky Medical Center (IL), Trillium Health Centre (CA), Emory University Hospital (US), Donald & Barbara Zucker School of Medicine at Hofstra/Northwell (US), Centre Hospitalier de l’Université de Montréal (CA), University of Nebraska Medical Center (US), Albany Medical Center Hospital (US), Stanford University (US)
Good health and well-being
COVID-19 Clinical Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon